Article
TERT Promoter Mutations Combined with TP53 Mutations as Potential Biomarkers for Hepatocellular Carcinoma Recurrence and Prognosis
2024-09-18
Abstract excerpt
<title>Abstract</title> <p>Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, and ranks among the most lethal malignancies globally, primarily due to its high rates of recurrence and metastasis. Despite the urgency, no reliable biomarkers currently exist for predicting tumor recurrence in HCC. Telomerase reverse transcriptase (<italic>TERT</italic>) promoter mutations (<italic>TERTpm</ital...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e4c2b1af-067a-5237-93db-1a837a86d83e
- DOI
- 10.21203/rs.3.rs-4767398/v1
